Features

Taking a productive alliance further

Taking a productive alliance further

Renewing its commitment to collaboration, an industry leader bets on Yale science

In 2011 the School of Medicine formed a research alliance with the biopharmaceutical company Gilead Sciences, Inc. to accelerate the discovery and development of new drugs to treat cancer. Called “transformative” by then-Yale President Richard C. Levin, the collaboration included an initial commitment of up to $40 million to support research at the medical school over four years.

Now, almost four years into the collaboration, the commitment has been renewed for an additional three years and...

Read more...

Taking a productive alliance further

Chair of biomedical engineering joins Institute of Medicine

W. Mark Saltzman, Ph.D., Goizueta Foundation Professor of Chemical and Biomedical Engineering at the School of Medicine, has been elected to the Institute of Medicine (IOM), one of the most prestigious bodies in health and medicine.

Saltzman’s research at the intersection of basic science and translational research aims to promote new methods for drug delivery and develop new biotechnologies to combat human disease....

Read more...

Neurosurgeon, a pioneer in genomic studies, is new chair

Neurosurgeon, a pioneer in genomic studies, is new chair

Murat Günel, M.D., an accomplished neurosurgeon and geneticist, has been named chair of the School of Medicine’s Department of Neurosurgery and chief of neurosurgery at Yale-New Haven Hospital (YNHH).

Günel’s clinical expertise is in treating complex brain aneurysms and vascular...

Read more...